Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ritchie

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
BMC Nephrology|October 3, 2021
Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney diseaseHelen V Alderson, Rajkumar Chinnadurai, Sara T Ibrahim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axisJoseph P Ritchie, Vishnu C Ramani, Yongsheng Ren, et al.
The Journal of Cell Biology|June 6, 2023
Ultrafast single-molecule imaging reveals focal adhesion nano-architecture and molecular dynamicsTakahiro K Fujiwara, Taka A Tsunoyama, Shinji Takeuchi, et al.
Mayo Clinic Proceedings|November 6, 2017
The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysisSimon D S Fraser, Anthony Fenton, Scott Harris, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
BMC Nephrology|October 3, 2021
Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney diseaseHelen V Alderson, Rajkumar Chinnadurai, Sara T Ibrahim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axisJoseph P Ritchie, Vishnu C Ramani, Yongsheng Ren, et al.
The Journal of Cell Biology|June 6, 2023
Ultrafast single-molecule imaging reveals focal adhesion nano-architecture and molecular dynamicsTakahiro K Fujiwara, Taka A Tsunoyama, Shinji Takeuchi, et al.
Mayo Clinic Proceedings|November 6, 2017
The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysisSimon D S Fraser, Anthony Fenton, Scott Harris, et al.
Pageof 16